RBA
IDXX icon

Richard Bernstein Advisors’s Idexx Laboratories IDXX Stock Holding History

Richard Bernstein Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-8,992
Closed -$4.4M – 323
2021
Q1 		$4.4M Sell
8,992
-2,149
-19% -$1.08M 0.1% 96
2020
Q4 		$5.57M Hold
11,141
– – 0.14% 68
2020
Q3 		$4.38M Hold
11,141
– – 0.12% 79
2020
Q2 		$3.68M Sell
11,141
-5,674
-34% -$1.64M 0.12% 99
2020
Q1 		$4.07M Sell
16,815
-2,663
-14% -$695K 0.14% 77
2019
Q4 		$5.09M Hold
19,478
– – 0.16% 85
2019
Q3 		$5.3M Hold
19,478
– – 0.17% 88
2019
Q2 		$5.36M Hold
19,478
– – 0.18% 83
2019
Q1 		$4.36M Buy
+19,478
New +$4.02M 0.14% 121

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Richard Bernstein Advisors's IDXX Position: Q2 2021 in Review

Richard Bernstein Advisors sold out of Idexx Laboratories (IDXX) in Q2 2021, closing a stake of 8,992 shares — an estimated $4.4M sold.

Richard Bernstein Advisors first reported a position in IDXX in Q1 2019 and held it in 9 quarters. The position peaked at $5.57M in Q4 2020. 1,034 funds tracked by Wall St. Rank hold IDXX as of Q2 2021.

  • Richard Bernstein Advisors reported no remaining Idexx Laboratories position as of Q2 2021 after selling out during the quarter.
  • Richard Bernstein Advisors sold 8,992 Idexx Laboratories shares in Q2 2021, an estimated $4.4M.
  • Richard Bernstein Advisors first reported a position in Idexx Laboratories in Q1 2019 and held it in 9 quarters.
  • Richard Bernstein Advisors's Idexx Laboratories position peaked at $5.57M in Q4 2020.
  • 1,034 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2021.

Based on Richard Bernstein Advisors's 13F filing for Q2 2021, filed 5 Aug 2021.